#news #biotech Bone Therapeutics’ cell therapy hits goal in phase 1/2a, but manufacturing changes slow progress

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bone Therapeutics’ cell therapy hits goal in phase 1/2a, but manufacturing changes slow progress .A phase 1/2a trial of Bone Therapeutics’ cell therapy treatment for delayed-union fractures has met its primary endpoint. Bone wants to move the therapy, ALLOB, into phase 2b on the strength of the data, but that plan is on hold as it adopts an industrialized manufacturing process.   

from FierceBiotech: Biotech https://ift.tt/2Qv9H9e